Proteomic approach to the diagnosis of acute coronary syndrome: preliminary results.
暂无分享,去创建一个
Gianfranco Antonelli | Gianfranco Amodio | Francesca Di Serio | Enzo Ruggieri | Rosalisa De Sario | Lucia Varraso | Nicola Pansini | F. Di Serio | N. Pansini | G. Antonelli | Enzo Ruggieri | G. Amodio | Lucia Varraso | Rosalisa De Sario
[1] T. Takala,et al. Serum carbonic anhydrase III and myoglobin concentrations in acute myocardial infarction. , 1990, Clinical chemistry.
[2] F. Dati,et al. Use of Biochemical Markers in Acute Coronary Syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage , 1999, Clinical chemistry and laboratory medicine.
[3] K. Linnet,et al. Evaluation of regression procedures for methods comparison studies. , 1993, Clinical chemistry.
[4] A. Wu,et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. , 2004, Clinical chemistry.
[5] L Graff,et al. Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction. , 2000, Clinical chemistry.
[6] Douglas G. Altman,et al. Practical statistics for medical research , 1990 .
[7] Carl J Pepine,et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.
[8] W. Gibler,et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. , 1999, Clinical chemistry.
[9] B. Lindahl,et al. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. , 2004, American heart journal.
[10] Hugo A. Katus,et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.
[11] P. Trerotoli,et al. Integration between point-of-care cardiac markers in an emergency/cardiology department and the central laboratory: methodological and preliminary clinical evaluation , 2005, Clinical chemistry and laboratory medicine.
[12] K. Huttunen,et al. The use of myoglobin/carbonic anhydrase III ratio as a marker for myocardial damage in patients with renal failure. , 1997, Clinica chimica acta; international journal of clinical chemistry.
[13] A. Wu,et al. Quality Specifications for Cardiac Troponin Assays , 2001, Clinical chemistry and laboratory medicine.
[14] L J Kricka,et al. Miniaturization of analytical systems. , 1998, Clinical chemistry.
[15] J S Alpert,et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.
[16] R H Christenson,et al. Characteristics of myoglobin, carbonic anhydrase III and the myoglobin/carbonic anhydrase III ratio in trauma, exercise, and myocardial infarction patients. , 2000, Clinica chimica acta; international journal of clinical chemistry.
[17] U. Hofmann,et al. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. , 1995, Clinical chemistry.
[18] M. Niemelä,et al. Serum myoglobin/carbonic anhydrase III ratio as a marker of reperfusion after myocardial infarction. , 2003, International journal of cardiology.
[19] E. Krause,et al. Isoenzyme BB of glycogen phosphorylase b and myocardial infarction , 1993, The Lancet.
[20] H. Väänänen,et al. Myoglobin/carbonic anhydrase III ratio: highly specific and sensitive early indicator for myocardial damage in acute myocardial infarction. , 1996, Clinical chemistry.
[21] Kato Kanefusa,et al. Distribution of immunoreactive carbonic anhydrase III in various human tissues determined by a sensitive enzyme immunoassay method , 1984 .
[22] W. Hermens,et al. Fatty acid-binding proteins as plasma markers of tissue injury. , 2005, Clinica chimica acta; international journal of clinical chemistry.
[23] J. Glatz,et al. Cellular fatty acid-binding proteins: current concepts and future directions , 2004, Molecular and Cellular Biochemistry.
[24] J. W. Schaeffer,et al. ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendations , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[25] J R Beck,et al. The use of relative operating characteristic (ROC) curves in test performance evaluation. , 1986, Archives of pathology & laboratory medicine.
[26] J. Mair. Glycogen phosphorylase isoenzyme BB to diagnose ischaemic myocardial damage. , 1998, Clinica chimica acta; international journal of clinical chemistry.
[27] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[28] J S Alpert,et al. 1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) , 1999, Circulation.
[29] J. Maessen,et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. , 1995, Circulation.
[30] E. Krause,et al. Early release of glycogen phosphorylase in patients with unstable angina and transient ST-T alterations. , 1994, British heart journal.